| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Obesity and Clinical Diabetes Research Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Phoenix, Arizona 85016
Address all correspondence and requests for reprints to: Joy C. Bunt, M.D., Ph.D., Obesity and Clinical Diabetes Research Section, National Institutes of Health, 4212 North 16th Street, Room 541-A, Phoenix, Arizona 85016. E-mail: jbunt{at}mail.nih.gov.
| Abstract |
|---|
|
|
|---|
Design/Participants: Forty-two Pima Indians, aged 711 yr, were identified retrospectively from maternal oral glucose tolerance tests as offspring of a diabetic pregnancy (22 ODM, eight males, 14 females) or offspring born before the mother developed diabetes (20 PRE, 12 males, eight females).
Setting/Main Outcome Measures: Weight, height, body mass index, percent body fat, blood pressure, and fasting concentrations of glucose, insulin, hemoglobin A1c (HbA1c), total cholesterol, triglycerides, and high-density lipoprotein-cholesterol were measured while staying in an in-patient clinical research unit and compared in cross-sectional analyses.
Results: After adjustment for age and gender, ODM had significantly higher concentrations of HbA1c (ODM = 5.7 ± 0.4, PRE = 5.0 ± 0.4%, P = 0.002), higher systolic (SBP) blood pressure (ODM = 118 ± 13, PRE = 107 ± 10 mm Hg; P = 0.02), and lower concentrations of high-density lipoprotein (ODM = 41 ± 9, PRE = 48 ± 6 mg/dl, P = 0.03) than PRE. Maternal diabetes status during pregnancy persisted as a significant determinant of SBP (beta = 7.50, P = 0.03) and HbA1c (beta = 0.43, P = 0.002), independent of age, gender, and percent body fat.
Conclusion: Intrauterine exposure to diabetes is a significant determinant of higher SBP and HbA1c during childhood, independent of adiposity and a genetic predisposition to T2DM. These data suggest that in utero exposure to diabetes confers an additional independent risk for the development of T2DM and/or cardiovascular disease later in life.
| Introduction |
|---|
|
|
|---|
Both obesity and hyperinsulinemia, either together or independently, are proposed to be unifying links between the insulin resistance syndrome and subsequent development of T2DM and CVD (19, 20, 21, 22). However, individual and ethnic differences in the presence of or relationships between the various components of the insulin resistance syndrome suggest that it is a heterogeneous disorder (22, 23, 24, 25, 26). Furthermore, the temporal relationships between this syndrome and subsequent development of T2DM and CVD vary among individuals and populations (27, 28). Finally, there are neither established criteria for the diagnosis of the insulin resistance syndrome in children nor a unified definition thereof (24, 26). Therefore, understanding the impact of the in utero environment on these variables during childhood, independent of adiposity or genetics, would be useful for earlier identification of high-risk individuals and for targeting more effective and timely intervention strategies.
A significant number of Pima Indian children are markedly overweight and hyperinsulinemic by as early as 5 yr of age (29). Interestingly, this population has a genetic predisposition for obesity and T2DM (30) but not CVD. Furthermore, within the population, intrauterine exposure to a diabetic environment is associated with a greater risk for onset of T2DM at a younger age (31) due to lower insulin secretory rates (and thus higher glucose levels) for a similar level of adiposity or insulin sensitivity (32). Once diabetic, offspring of diabetic pregnancies also have a greater risk for renal disease (33). However, it is not clear whether the offspring within this population are also at greater risk for developing other components of the insulin resistance syndrome such as dyslipidemia or hypertension, which are closely associated with obesity and subsequent development of CVD.
Our aim was to investigate whether maternal diabetes status during pregnancy is a determinant for risk factors associated with T2DM or CVD in offspring during childhood. Using previously collected data, we retrospectively compared cross-sectional measures of anthropometry, blood pressure, and fasting concentrations of lipids, glucose, insulin, and hemoglobin A1c (HbA1c) in children identified as either offspring of mothers with diabetes (either T2DM or gestational) during the index pregnancy (ODM) or offspring of mothers who were normal glucose tolerant during the pregnancy but who subsequently developed T2DM after the index pregnancy and before the age of 40 yr (PRE). The PRE group represents children who have a genetic risk of diabetes, whereas ODM children have both genetic and intrauterine risk factors for the disease. We hypothesized that the ODM group would have higher fasting glucose and HbA1c concentrations than the PRE group, independent of adiposity. We further hypothesized that the degree of adiposity, rather than the mothers diabetes status (MSTAT), would be the significant determinant of those variables associated with obesity (i.e. blood pressure and lipid and insulin concentrations).
| Subjects and Methods |
|---|
|
|
|---|
Forty-two (20 males, 22 females) Pima Indian children, aged 711 yr, were studied during the summer months of 20012003. Pima Indian children were of full Indian heritage and at least 50% Pima and/or Tohono OOdham heritage. Review of the mothers charts verified that the children were born full term (>37 wk) and that the pregnancies were uncomplicated with the exception of a diagnosis of maternal diabetes for 22 (eight males, 14 females) of these children.
Children and their mothers were admitted to the National Institutes of Health (NIH) Clinical Research Unit located at the Phoenix Indian Medical Center for a study primarily designed to evaluate patterns of food intake in this cohort. Health status was determined by medical history, physical examination, and urine and blood samples, and only healthy children were studied. Before participation, children and their mothers were fully advised of the nature and purpose of the study, and informed consent/assent was obtained. The experimental protocol was approved by the Institutional Review Boards of the NIDDK, the Phoenix Area Indian Health Service, and the Tribal Council of the Gila River Indian Community.
Determination of maternal diabetes status
Maternal diabetes status during pregnancy was determined from an oral glucose tolerance test performed during the last 180 d of pregnancy. In mothers who were normal glucose tolerant during the index pregnancy but who subsequently developed T2DM after the child was born and before the age of 40 yr, T2DM was diagnosed according to World Health Organization standards (2 h plasma glucose > 11.1 mM) (34) from an oral glucose tolerance test using a 75-g glucose load and at least one random plasma glucose level greater than 11.1 mM.
Anthropometry measurements
Height was measured without shoes. Body weight was measured while the children were wearing a preweighed robe. Body mass index (BMI) was calculated from weight and height measures [weight (kilograms)/height (square meters)] and converted to z-scores from percentiles established for age and gender (35). Body composition was determined using dual-energy x-ray absorptiometry as previously described (36). Waist circumference was measured at the level of the umbilicus while children were in the supine position. Measurements at birth (weight, length, and weight-for-length percentile) were obtained from the childs medical record.
Analytical measurements
After being on a standardized diet for 2 d in the Clinical Research Unit, fasting blood samples were drawn. Fasting serum glucose concentrations were measured using the glucose oxidase method (Beckman Instruments Inc., Fullerton, CA) and fasting serum lipids [triglycerides (TGs), total cholesterol (TC), and high-density lipoprotein (HDL)-cholesterol] were measured by the colorimetric method (Dimension clinical chemistry system; Dade-Behring, Deerfield, IL). In a subset of 31 children (17 ODM = six males, 11 females; 14 PRE = nine males, five females), fasting plasma insulin concentrations were measured with an automated RIA (ICN Biochemicals, Costa Mesa, CA). We were unable to obtain an adequate blood sample for fasting plasma insulin measurements in the remaining 11 children due to their request to discontinue the procedure.
Blood pressure measurements
Systolic (SBP) and diastolic (DBP) blood pressures were determined from the first and fifth Korotkoff sounds, respectively, using an appropriately sized cuff (37). Measurements were taken in the morning of the day of admission after the child had been quietly resting at least 5 min in a sitting position with the right arm supported and cubital fossa at heart level (38).
Statistical methods
All statistical analyses were performed using software of the SAS Institute (Cary, NC). Throughout the text, data are expressed as means ± SD. Fasting concentrations of TC, TGs, HDL, and insulin were log transformed (log10) to normalize the distribution before analysis. General linear models were used to assess the impact of MSTAT on all variables, after adjustment for age and gender. Variables that were statistically different between ODM and PRE children were further separately adjusted for each anthropometric variable using multiple regression analyses. The level of significance was set at P
0.05.
| Results |
|---|
|
|
|---|
Whereas the weight-for-length percentile at birth was higher (P = 0.03) in the ODM than the PRE group, none of the other anthropometric variables was different. Age was a significant determinant for all childhood variables (P < 0.02) except DBP and serum glucose and TGs. After adjustment for age and gender, the ODM group had significantly higher HbA1c (P = 0.02 unadjusted; P = 0.002 adjusted, Fig. 1
) and SBP (P = 0.02) and lower HDL (P = 0.03) levels than the PRE group.
|
|
Impact of MSTAT after adjustment for adiposity (Table 2
)
After adjustment for age, gender, and percent body fat, MSAT remained a significant determinant for SBP (Fig. 2
) but was no longer a significant determinant for HDL concentrations. Similar results were observed when substituting any of the anthropometric variables in the model (data not shown). MSTAT and age were the significant determinants of HbA1c.
|
|
| Discussion |
|---|
|
|
|---|
MSTAT was a significant determinant of childhood HbA1c but not fasting serum glucose concentrations. This suggests that postprandial glucose levels may be chronically higher in the ODM than the PRE children. In regression analysis, the slope (beta) for MSTAT as a determinant of HbA1c was 0.43%. A 1% increase in HbA1c represents a 35 mg/dl increase in mean plasma glucose (39), suggesting that this slope is roughly equivalent to a mean plasma glucose concentration that is 15 mg/dl higher. Indeed, impaired glucose tolerance often develops before an impaired fasting glucose level is detected (22, 28); unfortunately, we do not have oral glucose tolerance data in this particular cohort of children to support these suppositions. However, because this difference was independent of adiposity, differences in HbA1c may reflect differences in insulin secretion rather than insulin sensitivity. In our laboratory, adult ODM had a lower insulin secretory response to a glucose challenge, compared with non-ODM adults, independent of adiposity and insulin sensitivity (32). In the present cohort of Pima Indian children, there were no differences between the ODM and PRE children in measures of adiposity or fasting glucose or insulin concentrations. Although we cannot say for certain that a lower insulin secretory capacity is the mechanism for higher serum HbA1c levels in the ODM children, these data do suggest that the intrauterine environment might program glucose regulation in a way that is independent of adiposity or genetics.
Currently it is not clear whether HbA1c levels in children are a risk factor for T2DM; however, it was found to be associated with other known risk factors for T2DM in 4- to 17-yr-olds from the Third National Health and Nutrition Examination Survey (19881994) (40). That study also reported higher mean HbA1c percentages in African Americans and Mexican Americans than non-Hispanic Whites after controlling for age, sex, BMI, and poverty income ratio. In adults, there is evidence of a relationship between HbA1c and risk for CVD in both diabetic and nondiabetic populations. Specifically, after adjusting for other known risk factors, a 1% increase in HbA1c was associated with an 18% increased risk for CVD in adults with T2DM (41) and a 26% increase in cardiovascular events in nondiabetic adults (42). Taken together, these studies illustrate the need for clinical trials to determine the utility of HbA1c as an independent risk factor for T2DM and CVD in children and adults.
An unexpected finding was the significant relationship between intrauterine exposure to diabetes and a higher SBP that was independent of adiposity, weight, or height. Whereas other studies of offspring of diabetic mothers (with or without intrauterine exposure) have reported higher SBP (9, 10, 17), these ODM groups were also heavier or more obese. Because of these observations, and the observed association of increases in weight and adiposity with higher blood pressures in children (15, 16), we hypothesized that any differences in blood pressure would be attributed to relationships with adiposity rather than MSTAT. The clinical significance of this independent effect of the intrauterine environment on childhood SBP is not known; however, in this small cohort it should be noted that 10 of the 22 ODM children had a SBP that was more than the 90th percentile for age, gender, and height percentile (43). Although we cannot give a diagnosis of prehypertension or hypertension in these children without repeated measurements, mothers were advised to have their pediatricians closely monitor the children for hypertension in the future.
Birth weight has been identified as a significant factor linking the in utero environment with later development of hypertension (10, 25, 44, 45). Whereas there were no differences in birth weight between the ODM and PRE groups, the weight-for-length percentile was higher in the ODM group. However, none of the anthropometric measurements at birth were significant determinants for blood pressure in these children when included in the regression analyses.
It is difficult to speculate why our ODM cohort has higher SBP than our PRE cohort. Although we were able to account for factors such as maternal history of hypertension, birth size, anthropometry, gender, or age, we could not account for other potential confounding factors such as paternal or family history of hypertension. Furthermore, blood pressure was measured on only a single occasion, but it was measured under identical, standardized conditions in all children.
Of the mechanisms other than obesity that have been suggested to affect childhood hypertension (46), both hyperinsulinemia (47, 48) and renal parenchymal disease (46, 49) are plausible; however, there was no difference in fasting plasma insulin concentrations between the ODM and PRE children. Whether intrauterine exposure to diabetes has altered renal structure or function in a way that correlates with SBP in these children cannot be determined from these data but is worth further exploration, particularly because a relationship between intrauterine exposure to T2DM and urinary albumin excretion has already been demonstrated in adult diabetic Pima Indians (33).
Although ODM children had lower HDL levels than PRE children, once HDL levels were adjusted for levels of adiposity, the differences were no longer significant; however, HDL levels tended to remain lower in the ODM group. Intrauterine exposure to type 1 diabetes has been associated with higher TC to HDL ratios in 5- to 11-yr-old children, compared with matched controls (14), and lower HDL levels have also been reported in adult offspring of diabetic parents (17). However, as with blood pressure, these relationships appear to be related to differences in adiposity.
In summary, intrauterine exposure to diabetes is a significant determinant of higher SBP and higher serum concentrations of HbA1c during childhood independent of other risk factors such as adiposity or genetic predisposition to T2DM. Despite the limitations of retrospective analysis, these data suggest that intrauterine exposure to diabetes confers an additional independent risk for the development of T2DM and/or CVD later in life, and evidence for this association begins to emerge during childhood. Future research that includes prospective studies in children of diabetic pregnancies is warranted.
| Acknowledgments |
|---|
| Footnotes |
|---|
Abbreviations: BMI, Body mass index; CVD, cardiovascular disease; DBP, diastolic blood pressure; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; MSTAT, mothers diabetes status; ODM, offspring of mothers with diabetes (either T2DM or gestational) during the index pregnancy; PRE, offspring of mothers who were normal glucose tolerant during the pregnancy but who subsequently developed T2DM after the index pregnancy and before the age of 40 yr; SBP, systolic blood pressure; TC, total cholesterol; T2DM, type 2 diabetes; TG, triglyceride.
Received January 4, 2005.
Accepted March 21, 2005.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. A. Ingram, I. Z. Lien, L. E. Mead, M. Estes, D. N. Prater, E. Derr-Yellin, L. A. DiMeglio, and L. S. Haneline In Vitro Hyperglycemia or a Diabetic Intrauterine Environment Reduces Neonatal Endothelial Colony-Forming Cell Numbers and Function Diabetes, March 1, 2008; 57(3): 724 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dabelea The Predisposition to Obesity and Diabetes in Offspring of Diabetic Mothers Diabetes Care, July 1, 2007; 30(Supplement_2): S169 - S174. [Full Text] [PDF] |
||||
![]() |
A. D. Salbe, R. S. Lindsay, C. B. Collins, P. A. Tataranni, J. Krakoff, and J. C. Bunt Comparison of Plasma Insulin Levels after a Mixed-Meal Challenge in Children with and without Intrauterine Exposure to Diabetes J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 624 - 628. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |